{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T23:40:04Z","timestamp":1792194004004,"version":"4.4.0"},"reference-count":26,"publisher":"BMJ","issue":"7","license":[{"start":{"date-parts":[[2023,7,18]],"date-time":"2023-07-18T00:00:00Z","timestamp":1689638400000},"content-version":"unspecified","delay-in-days":17,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["BMJ Glob Health"],"accepted":{"date-parts":[[2023,6,25]]},"published-print":{"date-parts":[[2023,7]]},"abstract":"<jats:sec>\n                    <jats:title>Introduction<\/jats:title>\n                    <jats:p>Postacute sequelae resulting from SARS-CoV-2 infections (LONG-COVID) have been reported. The resulting added economic burden from the perspective of healthcare organisations is not clear. Therefore, this study aims to evaluate the additive healthcare costs among COVID-19 recoverees, in a large community-dwelling general population, as incurred by an insurer-provider organisation over time.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>In this historical cohort study, cost data from Clalit Health Services (CHS) were analysed. The primary endpoint was the direct cost incurred by CHS per month per person. Costs were measured for COVID-19 recoverees and matched controls, from January 2019 to January 2022. Difference in differences (DiDs) were calculated as the difference in mean monthly costs in cases and controls in the post-COVID-19 individual period, deducing their cost difference in a prepandemic 12 months baseline period.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Among N=642 868 community-dwelling COVID-19 recoverees, 268 948 (40.8%) were 0\u201319 years old and 63 051 (9.6%) were 60 years or older. A total of 16 017 (2.5%) of recoverees had been hospitalised during the acute phase of the COVID-19 disease. Costs in cases and controls converged after 16 months from recovery. The mean monthly cost incurred by CHS per COVID-19 recoverees over up to 15 months (mean: 8.25) of post-COVID-19 follow-up was higher by 8.2% (US$8.2) compared with matched controls. The excess cost attributable to post-COVID-19 effects (DID) was 7.6% of the cost in controls (US$7.7 per patient per month). Both net and relative DIDs were substantially higher in patients who required hospitalisation during the acute phase of COVID-19 and in older adults. Excess in hospitalisations, primary care physicians and medical specialists\u2019 visits-related costs were observed.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Long-term effects of SARS-CoV-2 infections translate into excess healthcare costs, months after recovery, hence requiring adjustments of funds allocation. These excess costs gradually diminish after recoveree, returning to baseline differences 16 months after recoveree.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1136\/bmjgh-2023-012588","type":"journal-article","created":{"date-parts":[[2023,7,18]],"date-time":"2023-07-18T21:55:46Z","timestamp":1689717346000},"page":"e012588","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":38,"title":["Estimating the economic burden of long-Covid: the additive cost of healthcare utilisation among COVID-19 recoverees in Israel"],"prefix":"10.1136","volume":"8","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2007-343X","authenticated-orcid":false,"given":"Yael","family":"Wolff Sagy","sequence":"first","affiliation":[{"name":"Branch of Planning and Strategy, Clalit Health Services, Tel Aviv, Israel"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ilan","family":"Feldhamer","sequence":"additional","affiliation":[{"name":"Branch of Planning and Strategy, Clalit Health Services, Tel Aviv, Israel"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuli","family":"Brammli-Greenberg","sequence":"additional","affiliation":[{"name":"Braun School of Public Health and Community Medicine, Hebrew University of Jerusalem, Jerusalem, Israel"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gil","family":"Lavie","sequence":"additional","affiliation":[{"name":"Branch of Planning and Strategy, Clalit Health Services, Tel Aviv, Israel"},{"name":"Ruth and Bruce Rappaport Faculty of Medicine, Technion Israel Institute of Technology, Haifa, Israel"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2023,7,18]]},"reference":[{"key":"2025072913332193000_8.7.e012588.1","doi-asserted-by":"crossref","DOI":"10.1016\/j.jeoa.2021.100328","article-title":"The economic burden of COVID-19 in the United States: estimates and projections under an infection-based herd immunity approach","volume":"20","author":"Chen","year":"2021","journal-title":"J Econ Ageing"},{"key":"2025072913332193000_8.7.e012588.2","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2020.19759"},{"key":"2025072913332193000_8.7.e012588.3","doi-asserted-by":"publisher","DOI":"10.1038\/d41586-021-01392-2"},{"key":"2025072913332193000_8.7.e012588.4","unstructured":"Mikkelsen ME , Abramoff B . COVID-19: evaluation and management of adults with persistent symptoms following acute illness (long COVID). UpToDate 2022. Available: https:\/\/www.uptodate.com\/contents\/covid-19-evaluation-and-management-of-adults-with-persistent-symptoms-following-acute-illness-long-covid"},{"key":"2025072913332193000_8.7.e012588.5","unstructured":"Ayoubkhani D , Munro M . n.d. Prevalence of ongoing symptoms following Coronavirus (COVID-19) infection in the UK. data and analyses from census 2021: 3 March 2022. office of national statistics, UK. Available: https:\/\/www.ons.gov.uk\/peoplepopulationandcommunity\/healthandsocialcare\/conditionsanddiseases\/bulletins\/prevalenceofongoingsymptomsfollowingcoronavirusCovid19infectionintheuk\/3march2022"},{"key":"2025072913332193000_8.7.e012588.6","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2021.3331"},{"key":"2025072913332193000_8.7.e012588.7","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2021.11417","article-title":"Assessment of the frequency and variety of persistent symptoms among patients with COVID-19: A systematic review","volume":"4","author":"Nasserie","year":"2021","journal-title":"JAMA Netw Open"},{"key":"2025072913332193000_8.7.e012588.8","doi-asserted-by":"crossref","DOI":"10.1136\/bmjgh-2021-005427","article-title":"Characterizing long COVID: a living systematic review","volume":"6","author":"Michelen","year":"2021","journal-title":"BMJ Glob Health"},{"key":"2025072913332193000_8.7.e012588.9","doi-asserted-by":"publisher","DOI":"10.1016\/s2213-2600(21)00383-0"},{"key":"2025072913332193000_8.7.e012588.10","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(21)01755-4\/ATTACHMENT\/5440AE6D-9DED-4100-8EE6-77F72BA95154\/MMC1.PDF"},{"key":"2025072913332193000_8.7.e012588.11","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1016\/S2213-2600(21)00174-0","article-title":"3-month, 6-month, 9-month, and 12-month respiratory outcomes in patients following COVID-19-related Hospitalisation: a prospective study","volume":"9","author":"Wu","year":"2021","journal-title":"Lancet Respir Med"},{"key":"2025072913332193000_8.7.e012588.12","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-021-03553-9"},{"key":"2025072913332193000_8.7.e012588.13","doi-asserted-by":"crossref","unstructured":"Cohen K , Ren S , Heath K , et al . Risk of persistent and new clinical sequelae among adults aged 65 years and older during the post-acute phase of SARS-Cov-2 infection: retrospective cohort study BMJ. BMJ 2022:e068414. doi:10.1136\/bmj-2021-068414","DOI":"10.1136\/bmj-2021-068414"},{"key":"2025072913332193000_8.7.e012588.14","first-page":"1","article-title":"Israel \u2013 health system review","volume":"17","author":"Rosen","year":"2015","journal-title":"Health Syst Transit"},{"key":"2025072913332193000_8.7.e012588.15","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2022.25657","article-title":"Health care utilization in the 6 months following SARS-Cov-2 infection","volume":"5","author":"Tartof","year":"2022","journal-title":"JAMA Netw Open"},{"key":"2025072913332193000_8.7.e012588.16","doi-asserted-by":"publisher","DOI":"10.1111\/0034-6527.00321"},{"key":"2025072913332193000_8.7.e012588.17","first-page":"145","article-title":"Comorbidity characterization among eMERGE institutions: A pilot evaluation with the Johns Hopkins adjusted clinical groups\u00ae system","volume":"2019","author":"Taylor","year":"2019","journal-title":"AMIA Jt Summits Transl Sci Proc"},{"key":"2025072913332193000_8.7.e012588.18","doi-asserted-by":"crossref","DOI":"10.1136\/bmj-2022-072529","article-title":"Long Covid outcomes at one year after mild SARS-Cov-2 infection: nationwide cohort study","volume":"380","author":"Mizrahi","year":"2023","journal-title":"BMJ"},{"key":"2025072913332193000_8.7.e012588.19","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2020-045343","article-title":"Impact of COVID-19 pandemic on utilisation of Healthcare services: a systematic review","volume":"11","author":"Moynihan","year":"2021","journal-title":"BMJ Open"},{"key":"2025072913332193000_8.7.e012588.20","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2020-048151","article-title":"Trends in Healthcare utilisation during COVID-19: a longitudinal study from the UK","volume":"11","author":"Howarth","year":"2021","journal-title":"BMJ Open"},{"key":"2025072913332193000_8.7.e012588.21","doi-asserted-by":"crossref","first-page":"1699","DOI":"10.1007\/s11739-022-02991-1","article-title":"The impact of COVID-19 pandemic on emergency Department visits and associated mortality during 14 months of the pandemic in Israel","volume":"17","author":"Sagy","year":"2022","journal-title":"Intern Emerg Med"},{"key":"2025072913332193000_8.7.e012588.22","doi-asserted-by":"crossref","first-page":"713","DOI":"10.15585\/mmwr.mm7121e1","article-title":"Post\u2013COVID conditions among adult COVID-19 survivors aged 18\u201364 and \u226565 years\u2014United States","volume":"71","author":"Bull-Otterson","year":"2020","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"2025072913332193000_8.7.e012588.23","unstructured":"Centers for Disease Control and Prevention . Long COVID: household pulse survey. 2022. Available: https:\/\/www.cdc.gov\/nchs\/covid19\/pulse\/long-covid.htm"},{"key":"2025072913332193000_8.7.e012588.24","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.ijid.2022.12.002","article-title":"Risk factors, health outcomes, Healthcare services utilization, and direct medical costs of patients with long COVID","volume":"128","author":"Tene","year":"2023","journal-title":"Int J Infect Dis"},{"key":"2025072913332193000_8.7.e012588.25","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(22)00941-2"},{"key":"2025072913332193000_8.7.e012588.26","unstructured":"Ho S . Long COVID could cost the economy trillions, experts predict. n.d. Available: https:\/\/www.webmd.com\/covid\/news\/20220928\/long-covid-could-cost-economy-trillions-experts"}],"container-title":["BMJ Global Health"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/bmjgh-2023-012588","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,29]],"date-time":"2025-07-29T20:33:29Z","timestamp":1753821209000},"score":1,"resource":{"primary":{"URL":"https:\/\/gh.bmj.com\/lookup\/doi\/10.1136\/bmjgh-2023-012588"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,7]]},"references-count":26,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2023,7,18]]},"published-print":{"date-parts":[[2023,7]]}},"alternative-id":["10.1136\/bmjgh-2023-012588"],"URL":"https:\/\/doi.org\/10.1136\/bmjgh-2023-012588","relation":{},"ISSN":["2059-7908"],"issn-type":[{"value":"2059-7908","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,7]]}}}